Yahoo
NYSE - Delayed Quote USD

Trulieve Cannabis Corp. (TRLV)

10.28 -0.32 (-3.02%)
At close: October 30 at 4:00:03 PM EDT
10.30 +0.02 (+0.19%)
After hours: October 30 at 6:53:37 PM EDT
Chart Range Bar
Loading chart for TRLV
  • Previous Close 10.60
  • Open 10.46
  • Bid 10.20 x 20000
  • Ask 10.18 x 20000
  • Day's Range 9.91 - 10.48
  • 52 Week Range 4.62 - 13.28
  • Volume 1,412,726
  • Avg. Volume 1,698,737
  • Market Cap (intraday) 1.98B
  • Beta (5Y Monthly) 1.80
  • PE Ratio (TTM) --
  • EPS (TTM) -2.43
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 18.18
  • Zacks Rating Neutral

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.

www.trulieve.com

5,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TRLV
18.30%
S&P 500 (^GSPC)
10.73%

1-Year Return

TRLV
48.34%
S&P 500 (^GSPC)
11.11%

3-Year Return

TRLV
157.71%
S&P 500 (^GSPC)
81.91%

5-Year Return

TRLV
59.16%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 271M
Earnings -406M
Profit Margin -149.82%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-400M
-200M
0
200M
-100.0%
-50.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

15.00
18.18 Average
10.28 Current
21.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/23/2026
Analyst Cantor Fitzgerald
Rating Action Reiterates
Rating Overweight
Price Action Maintains
Price Target 15 -> 15

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -41.55%

  • Return on Assets (ttm)

    3.28%

  • Return on Equity (ttm)

    -47.65%

  • Revenue (ttm)

    1.14B

  • Net Income Avi to Common (ttm)

    -467.83M

  • Diluted EPS (ttm)

    -2.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    325.42M

  • Total Debt/Equity (mrq)

    75.45%

  • Levered Free Cash Flow (ttm)

    232.04M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: